Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Nilsson

Showing results (51-60 of 177) with videos related to

Pageof 18
Sort By:
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancerAdalsteinn Gunnlaugsson, Elisabeth Kjellén, Per Nilsson, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2020
Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016Kerri Beckmann, Hans Garmo, Per Nilsson, et al.
Clinical and Translational Radiation Oncology|July 3, 2020
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome - 5 year follow-up of a prospective observational studyAdalsteinn Gunnlaugsson, Elisabeth Kjellén, Ola Bratt, et al.
Frontiers in Immunology|May 11, 2026
Nerve growth factor responsive elements modulate immune cell inflammation and are dysregulated in an Alzheimer's disease mouse modelRuchi Gera, Giuseppe Mocci, Simone Tambaro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2022
Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer's disease pathology in mouse modelsShaffi Manchanda, Lorena Galan-Acosta, Axel Abelein, et al.
Acta Oncologica (Stockholm, Sweden)|November 23, 2006
"Distributed proton radiation therapy"--a new concept for advanced competence supportMikael Karlsson, Thomas Björk-Eriksson, Olof Mattsson, et al.
Journal of Cellular and Molecular Medicine|February 18, 2010
Gene therapy in Alzheimer's disease - potential for disease modificationPer Nilsson, Nobuhisa Iwata, Shin-ichi Muramatsu, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer's DiseaseDaniela Enache, Joana B Pereira, Vesna Jelic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 2014
Haematological toxicity in adult patients receiving craniospinal irradiation--indication of a dose-bath effectKristoffer Petersson, Maria Gebre-Medhin, Crister Ceberg, et al.
International Journal of Molecular Sciences|April 13, 2024
DEAD Box Helicase 24 Is Increased in the Brain in Alzheimer's Disease and <i>App</i> Mice and Influences Presymptomatic PathologyMichael Axenhus, Tosca Doeswijk, Per Nilsson, et al.
Pageof 18

Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancerAdalsteinn Gunnlaugsson, Elisabeth Kjellén, Per Nilsson, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2020
Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016Kerri Beckmann, Hans Garmo, Per Nilsson, et al.
Clinical and Translational Radiation Oncology|July 3, 2020
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome - 5 year follow-up of a prospective observational studyAdalsteinn Gunnlaugsson, Elisabeth Kjellén, Ola Bratt, et al.
Frontiers in Immunology|May 11, 2026
Nerve growth factor responsive elements modulate immune cell inflammation and are dysregulated in an Alzheimer's disease mouse modelRuchi Gera, Giuseppe Mocci, Simone Tambaro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2022
Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer's disease pathology in mouse modelsShaffi Manchanda, Lorena Galan-Acosta, Axel Abelein, et al.
Acta Oncologica (Stockholm, Sweden)|November 23, 2006
"Distributed proton radiation therapy"--a new concept for advanced competence supportMikael Karlsson, Thomas Björk-Eriksson, Olof Mattsson, et al.
Journal of Cellular and Molecular Medicine|February 18, 2010
Gene therapy in Alzheimer's disease - potential for disease modificationPer Nilsson, Nobuhisa Iwata, Shin-ichi Muramatsu, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer's DiseaseDaniela Enache, Joana B Pereira, Vesna Jelic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 2014
Haematological toxicity in adult patients receiving craniospinal irradiation--indication of a dose-bath effectKristoffer Petersson, Maria Gebre-Medhin, Crister Ceberg, et al.
International Journal of Molecular Sciences|April 13, 2024
DEAD Box Helicase 24 Is Increased in the Brain in Alzheimer's Disease and <i>App</i> Mice and Influences Presymptomatic PathologyMichael Axenhus, Tosca Doeswijk, Per Nilsson, et al.
Pageof 18